Clearbridge Investments, LLC Applied Genetic Technologies Corp Transaction History

Clearbridge Investments, LLC

  • $123 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2019

May 15, 2019
SELL
$2.62 - $4.44 $1,341 - $2,273
-512 Closed
0 $0
Q2 2018

Aug 14, 2018
SELL
$3.7 - $5.65 $2,590 - $3,955
-700 Reduced 57.76%
512 $2,000
Q2 2017

Aug 14, 2017
BUY
N/A
1,212
1,212 $6,000

About APPLIED GENETIC TECHNOLOGIES CORP

AGTC Quotes by TradingView
  • Ticker AGTC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 67,632,200
  • Description
  • Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. Its advanced product candidates include three ophthalmology development programs across two targets, including X-linked retinitis pigmentosa, which is in the Pha...
More about AGTC
Track This Portfolio

Track Clearbridge Investments, LLC Portfolio

Follow Clearbridge Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clearbridge Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clearbridge Investments, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email